Trinity Biotech plc
TRIB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $79,022 | $82,291 | $166,987 | $149,447 |
| - Cash | $5,167 | $3,691 | $6,578 | $25,910 |
| + Debt | $100,764 | $67,427 | $72,200 | $99,157 |
| Enterprise Value | $174,619 | $146,027 | $232,609 | $222,694 |
| Revenue | $61,555 | $56,832 | $62,521 | $81,149 |
| % Growth | 8.3% | -9.1% | -23% | – |
| Gross Profit | $21,441 | $19,450 | $22,048 | $33,454 |
| % Margin | 34.8% | 34.2% | 35.3% | 41.2% |
| EBITDA | -$16,905 | -$24,098 | -$16,713 | $10,592 |
| % Margin | -27.5% | -42.4% | -26.7% | 13.1% |
| Net Income | -$31,789 | -$24,018 | -$41,002 | $875 |
| % Margin | -51.6% | -42.3% | -65.6% | 1.1% |
| EPS Diluted | -1.77 | -3.2 | -5.2 | 0.16 |
| % Growth | 44.7% | 38.5% | -3,350% | – |
| Operating Cash Flow | -$4,191 | -$11,557 | -$921 | $13,238 |
| Capital Expenditures | -$10,064 | -$803 | -$5,977 | -$8,691 |
| Free Cash Flow | -$14,255 | -$12,360 | -$6,898 | $4,547 |